Vor Biopharma Newsroom

Vor Biopharma Price Target Maintained With a $12.00/Share by JMP Securities

Dow JonesDec 11 00:51

Vor Biopharma Analyst Ratings

BenzingaDec 11 00:42

Oppenheimer Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $8

Futu NewsDec 10 05:31

Stifel Nicolaus Remains a Buy on Vor Biopharma (VOR)

TipRanksDec 9 20:59

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Recursion Pharmaceuticals (RXRX) and AN2 Therapeutics, Inc. (ANTX)

TipRanksNov 25 14:02

Barclays Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $3

Futu NewsNov 11 16:35

Vor Biopharma Is Maintained at Outperform by Baird

Dow JonesNov 8 20:41

HC Wainwright & Co. Reiterates Buy on Vor Biopharma, Maintains $17.5 Price Target

BenzingaNov 8 19:13

Vor Biopharma Analyst Ratings

BenzingaNov 8 19:12

Barclays Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $3

Futu NewsNov 8 18:37

Barclays Keeps Their Buy Rating on Vor Biopharma (VOR)

TipRanksNov 8 17:53

Analysts Offer Insights on Healthcare Companies: SAB Biotherapeutics (SABS) and Vor Biopharma (VOR)

TipRanksSep 10 22:40

Vor Biopharma Price Target Maintained With a $12.00/Share by JMP Securities

Dow JonesSep 6 23:03

Evercore Initiates Vor Biopharma(VOR.US) With Buy Rating

Futu NewsSep 6 20:31

HC Wainwright & Co. Reiterates Buy on Vor Biopharma, Maintains $17.5 Price Target

BenzingaSep 6 18:29

Vor Biopharma Analyst Ratings

BenzingaSep 6 18:24

Barclays Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $3

Futu NewsSep 6 17:32

Vor Biopharma (VOR) Receives a Buy From Barclays

TipRanksSep 6 16:57

Promising Clinical Outcomes and Strategic Acquisitions Bolster Buy Rating for Vor Biopharma

TipRanksSep 6 12:39

Vor Biopharma Analyst Ratings

BenzingaAug 14 23:22